Exfoliative epitheliopathy of bullous keratopathy with breaches in the MUC16 glyocalyx

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 9, 2009, Pages 4060-4064

  Glasgow, Ben J ^a   Gasymov, Oktay K ^a   Casey, Richard C ^a  

^a JULES STEIN EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; MUCIN 1; MUCIN 16; UNCLASSIFIED DRUG; CA 125 ANTIGEN; MEMBRANE PROTEIN; MUC16 PROTEIN, HUMAN;

AGED; ARTICLE; CELL SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEA EPITHELIUM; EPITHELIUM CELL; GLYCOCALYX; HUMAN; HUMAN TISSUE; KERATOPATHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOPHAKIA; CELL COUNT; CORNEA DISEASE; ENZYME IMMUNOASSAY; METABOLISM; PATHOLOGY; SCANNING ELECTRON MICROSCOPY; ULTRASTRUCTURE;

AGED; CA-125 ANTIGEN; CELL COUNT; CORNEAL DISEASES; EPITHELIUM, CORNEAL; GLYCOCALYX; HUMANS; IMMUNOENZYME TECHNIQUES; MEMBRANE PROTEINS; MICROSCOPY, ELECTRON, SCANNING;

EID: 70349263463     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-3361     Document Type: Article

References (40)

1. Cosar CB, Sridhar MS, Cohen EJ, et al. Indications for penetrating keratoplasty and associated procedures: 1996-2000. Cornea. 2002;21:148-151.
2. Dobbins KR, Price FW Jr, Whitson WE. Trends in the indications for penetrating keratoplasty in the Midwestern United States. Cornea. 2000;19:813-816.
3. Chen WL, Hu FR, Wang IJ. Changing indications for penetrating keratoplasty in Taiwan from 1987 to 1999. Cornea. 2001;20:141-144.
4. Liu E, Slomovic AR. Indications for penetrating keratoplasty in Canada: 1986-1995. Cornea. 1997;16:414-419.
5. Narayanan R, Gaster RN, Kenney MC. Pseudophakic corneal edema: a review of mechanisms and treatments. Cornea. 2006;25: 993-1004.
6. Taylor DM, Atlas BF, Romanchuk KG, Stern AL. Pseudophakic bullous keratopathy. Ophthalmology. 1983;90:19-24.
7. Eagle RC Jr, Laibson PR, Arentsen JJ. Epithelial abnormalities in chronic corneal edema: a histopathological study. Trans Am Ophthalmol Soc. 1989;87:107-119; discussion 119-124.
8. Yuen HK, Rassier CE, Jardeleza MS, et al. A morphologic study of Fuchs dystrophy and bullous keratopathy. Cornea. 2005;24:319-327.
9. Akhtar S, Bron AJ, Hawksworth NR, Bonshek RE, Meek KM. Ultrastructural morphology and expression of proteoglycans, betaig-h3, tenascin-C, fibrillin-1, and fibronectin in bullous keratopathy. Br J Ophthalmol. 2001;85:720-731.
10. Spirin KS, Ljubimov AV, Castellon R, et al. Analysis of gene expression in human bullous keratopathy corneas containing limiting amounts of RNA. Invest Ophthalmol Vis Sci. 1999;40:3108-3115.
11. Ljubimov AV, Saghizadeh M, Pytela R, Sheppard D, Kenney MC. Increased expression of tenascin-C-binding epithelial integrins in human bullous keratopathy corneas. J Histochem Cytochem. 2001; 49:1341-1350.
12. Li QJ, Ashraf MF, Shen DF, et al. The role of apoptosis in the pathogenesis of Fuchs endothelial dystrophy of the cornea. Arch Ophthalmol. 2001;119:1597-1604.
13. Szentmary N, Szende B, Suveges I. Epithelial cell, keratocyte, and endothelial cell apoptosis in Fuchs' dystrophy and in pseudophakic bullous keratopathy. Eur J Ophthalmol. 2005;15:17-22.
14. Szentmary N, Szende B, Suveges I. P53, CD95, cathepsin and survivin pathways in Fuchs' dystrophy and pseudophakic bullous keratopathy corneas. Histol Histopathol. 2008;23:911-916.
15. Inatomi T, Spurr-Michaud S, Tisdale AS, Gipson IK. Human corneal and conjunctival epithelia express MUC1 mucin. Invest Ophthalmol Vis Sci. 1995;36:1818-1827.
16. Pflugfelder SC, Liu Z, Monroy D, et al. Detection of sialomucin complex (MUC4) in human ocular surface epithelium and tear fluid. Invest Ophthalmol Vis Sci. 2000;41:1316-1326.
17. Argueso P, Spurr-Michaud S, Russo CL, Tisdale A, Gipson IK. MUC16 mucin is expressed by the human ocular surface epithelia and carries the H185 carbohydrate epitope. Invest Ophthalmol Vis Sci. 2003;44:2487-2495.
18. Yin BW, Lloyd KO. Molecular cloning of the CA125 ovarian cancer antigen: identification as a new mucin, MUC16. J Biol Chem. 2001;276:27371-27375.
19. Argueso P, Tisdale A, Spurr-Michaud S, Sumiyoshi M, Gipson IK. Mucin characteristics of human corneal-limbal epithelial cells that exclude the Rose Bengal anionic dye. Invest Ophthalmol Vis Sci. 2006;47:113-119.
20. Blalock TD, Spurr-Michaud SJ, Tisdale AS, Gipson IK. Release of membrane-associated mucins from ocular surface epithelia. Invest Ophthalmol Vis Sci. 2008;49:1864-1871.
21. Inatomi T, Spurr-Michaud S, Tisdale AS, Zhan Q, Feldman ST, Gipson IK. Expression of secretory mucin genes by human conjunctival epithelia. Invest Ophthalmol Vis Sci. 1996;37:1684-1692.
22. Gipson IK, Hori Y, Argueso P. Character of ocular surface mucins and their alteration in dry eye disease. Ocul Surf. 2004;2:131-148.
23. Dogru M, Asano-Kato N, Tanaka M, et al. Ocular surface and MUC5AC alterations in atopic patients with corneal shield ulcers. Curr Eye Res. 2005;30:897-908.
24. Gasymov OK, Abduragimov AR, Prasher P, Yusifov TN, Glasgow BJ. Tear lipocalin: evidence for a scavenging function to remove lipids from the human corneal surface. Invest Ophthalmol Vis Sci. 2005;46:3589-3596.
25. Hogan MJ, Alvarado JA, Weddell JE. Histology of the Human Eye: An Atlas and Textbook. Philadelphia: Saunders; 1971:xiii, 687.
26. Weibel ER. Stereological Methods. New York: Academic Press; 1979:101-161.
27. Blumcke S, Morgenroth K Jr. The stereo ultrastructure of the external and internal surface of the cornea. J Ultrastruct Res. 1967;18:502-518.
28. Glasgow BJ. Tissue expression of lipocalins in human lacrimal and von Ebner's glands: colocalization with lysozyme. Graefes Arch Clin Exp Ophthalmol. 1995;233:513-522.
29. Theodoropoulos G, Carraway KL. Molecular signaling in the regulation of mucins. J Cell Biochem. 2007;102:1103-1116.
30. Ren H, Wilson G. The effect of a shear force on the cell shedding rate of the corneal epithelium. Acta Ophthalmol Scand. 1997;75:383-387.
31. Ren H, Wilson G. Apoptosis in the corneal epithelium. Invest Ophthalmol Vis Sci. 1996;37:1017-1025.
32. Blalock TD, Spurr-Michaud SJ, Tisdale AS, et al. Functions of MUC16 in corneal epithelial cells. Invest Ophthalmol Vis Sci. 2007;48:4509-4518.
33. Gipson IK. Distribution of mucins at the ocular surface. Exp Eye Res. 2004;78:379-388.
34. Singh AP, Chauhan SC, Bafna S, et al. Aberrant expression of transmembrane mucins, MUC1 and MUC4, in human prostate carcinomas. Prostate. 2006;66:421-429.
35. Danjo Y, Watanabe H, Tisdale AS, et al. Alteration of mucin in human conjunctival epithelia in dry eye. Invest Ophthalmol Vis Sci. 1998;39:2602-2609.
36. Dogru M, Matsumoto Y, Okada N, et al. Alterations of the ocular surface epithelial MUC16 and goblet cell MUC5AC in patients with atopic keratoconjunctivitis. Allergy. 2008;63:1324-1334.
37. Gipson IK, Yankauckas M, Spurr-Michaud SJ, Tisdale AS, Rinehart W. Characteristics of a glycoprotein in the ocular surface glycocalyx. Invest Ophthalmol Vis Sci. 1992;33:218-227.
38. Dartt DA. Control of mucin production by ocular surface epithelial cells. Exp Eye Res. 2004;78:173-185.
39. Paulsen F, Jager K, Worlitzsch D, et al. Regulation of MUC16 by inflammatory mediators in ocular surface epithelial cell lines. Ann Anat. 2008;190:59-70.
40. Sjogren H. Zur kenntnis der keratoconjunctivitis sicca. Acta Ophthalmol (Copenh). 1933;(suppl 11):151.